Apex Formulations Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 1.80 M
- Company Age 26 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.98 M
- Satisfied Charges ₹ 8.52 Cr
- Revenue Growth 11.93%
- Profit Growth 112.11%
- Ebitda 71.22%
- Net Worth 48.57%
- Total Assets 48.33%
About Apex Formulations
Apex Formulations Private Limited (AFPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 April 1998 and has a history of 26 years and ten months. Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Apex Formulation Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.80 M.
The company currently has active open charges totaling ₹6.98 M. The company has closed loans amounting to ₹8.52 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vipul Shah and Nishaben Shah serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231GJ1998PTC033963
- Company No.
033963
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 1998
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Pharma
What products or services does Apex Formulations Private Limited offer?
Apex Formulations Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Food Supplement, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Anti Infective Drugs & Medicines.
Who are the key members and board of directors at Apex Formulations?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vipul Shah  | Managing Director | 20-Apr-1998 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nishaben Shah | Director | 20-Apr-1998 | Current |
Financial Performance of Apex Formulations.
Apex Formulations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.93% increase. The company also saw a substantial improvement in profitability, with a 112.11% increase in profit. The company's net worth Soared by an impressive increase of 48.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apex Formulations?
In 2023, Apex Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹6.98 M
Satisfied Charges
₹85.22 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Feb 2024 | Hdfc Bank Limited | ₹6.98 M | Open |
| 25 Apr 2017 | Hdfc Bank Limited | ₹1.62 Cr | Satisfied |
| 16 Apr 2015 | Axis Bank Limited | ₹1.05 M | Satisfied |
| 29 Nov 2011 | Hdb Financial Services Limited | ₹1.90 M | Satisfied |
| 04 Apr 2006 | Central Bank Of India | ₹3.14 M | Satisfied |
How Many Employees Work at Apex Formulations?
Apex Formulations has a workforce of 4 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apex Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apex Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.